Omicron News and Research

RSS

Researchers create model to explore SARS-CoV-2 Omicron and Delta supremacy

In a new study, researchers have created a model to help identify the dynamics of Delta and Omicron infection in the US, as well as explore the effects of various factors on the overall COVID-19 pandemic.

28 Feb 2022

Immunity before and after the SARS-CoV-2 Omicron variant in South Africa

Researchers conducted a national epidemiological survey to determine the seropositivity against SARS-CoV-2 before the emergence of the novel Omicron variant of concern.

28 Feb 2022

Molecular insights on the possible connection of SARS-CoV-2 and nicotinic acetylcholine receptors

A recent study assessed the mechanism by which SARS-CoV-2 Omicron and Alpha VOCs inhibit the SARS-CoV-2 spike protein and mitigate the risk of a multisystem inflammatory syndrome in children.

28 Feb 2022

Triple antibody cocktail is a promising candidate for immunotherapy against SARS-CoV-2 variants of concern

Researchers generated a panel of bnAbs against SARS-CoV, SARS-CoV-2, and its variant VOCs, including Omicron from sequentially immunized mice.

28 Feb 2022

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Researchers evaluated the pathogenicity and replication potential of SARS-CoV-2 VOC Omicron lineage, BA.2 in immunocompetent mice and hamsters.

28 Feb 2022

Vaccination reduces risk of long-COVID

A new study posted on the medRxiv* preprint server investigated the difference between the likelihood of symptoms, 12 weeks after SARS-CoV-2 infection, among individuals who received two COVID-19 vaccination doses and unvaccinated individuals.

27 Feb 2022

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

A new study estimates vaccine effectiveness against SARS-CoV-2 Omicron variant in indoor entertainment settings in Australia.

27 Feb 2022

Will Omicron BA.2 become the next dominant variant?

A new study presents a comprehensive analysis of the potential of both Omicron BA.2 and BA.3 to become the next dominant circulating SARS-CoV-2 strain.

27 Feb 2022

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

A new study discusses the emergence of new variants of SARS-CoV-2 that can escape antibody-mediated neutralization, as opposed to other Sarbecoviruses.

27 Feb 2022

Clinical severity of patients hospitalized with SARS-CoV-2 infection during the Omicron wave in South Africa

The study findings show that the Omicron-dominant fourth wave of COVID-19 reversed the rising SARS-CoV-2 cases and hospitalization trend seen in the previous three waves in South Africa.

25 Feb 2022

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Scientists evaluated the incidence and severity of breakthrough SARS-CoV-2 infections among individuals with immune-mediated inflammatory diseases undergoing B cell depleting therapy.

25 Feb 2022

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

Researchers characterized humoral and SARS-CoV-2 S-specific T cell responses in IBD patients who received two-dose mRNA-based COVID-19 vaccination series.

25 Feb 2022

Study identifies higher infection rate and lower disease severity during Omicron wave in US

Scientists from the Case Western Reserve University, USA, have recently conducted a study in collaboration with the National Institutes of Health, USA, to investigate the incidence rates and disease severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the United States before and after the emergence of omicron variant.

24 Feb 2022

Omicron News and Research

Researchers create model to explore SARS-CoV-2 Omicron and Delta supremacy

Immunity before and after the SARS-CoV-2 Omicron variant in South Africa

Molecular insights on the possible connection of SARS-CoV-2 and nicotinic acetylcholine receptors

Triple antibody cocktail is a promising candidate for immunotherapy against SARS-CoV-2 variants of concern

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Vaccination reduces risk of long-COVID

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

Will Omicron BA.2 become the next dominant variant?

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

Clinical severity of patients hospitalized with SARS-CoV-2 infection during the Omicron wave in South Africa

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

T cell responses in inflammatory bowel disease patients on immune-modifying agents after mRNA COVID-19 vaccination

Study identifies higher infection rate and lower disease severity during Omicron wave in US

Should SARS-CoV-2 Omicron be considered a serotype?

Vaccinated adults were less likely to land in intensive care during the omicron surge

Study finds two doses of COVID-19 vaccines were insufficient to neutralize the SARS-CoV-2 Omicron variant

Third dose of mRNA-based COVID-19 vaccine efficiently recalls Omicron-reactive B cell memory

Metalloproteinase-dependent entry pathway differentially used by SARS-CoV-2 Delta, Alpha, and Omicron variants

Covid aid to protect Montana prisons and jails sits unused

Omicron BA. 2 reinfections can occur shortly following BA.1 infection

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News